XML 42 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Stock Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Share-Based Payment Arrangement, Option, Activity
The following table summarizes stock option activity during the nine months ended September 30, 2025:
Number of SharesWeighted-
Average
Exercise
Price
Stock options outstanding at December 31, 2024
3,409,912 $22.63 
Exercised
(270,747)15.92 
Forfeited
(89,180)24.46 
Expired
(394,660)39.39 
Stock options outstanding at September 30, 2025
2,655,325 20.67 
Stock options exercisable at September 30, 2025
1,911,733 $22.77 
Summary of Share-Based Payment Arrangement, Restricted Stock Unit, Activity
The following table summarizes RSUs and PSUs activity during the nine months ended September 30, 2025:
Number of Shares
Weighted-
Average
Grant Date
Fair Value
RSUs and PSUs outstanding at December 31, 2024
4,842,670 $15.38 
RSUs granted
1,542,206 18.90 
RSUs vested
(1,520,059)15.92 
RSUs forfeited
(828,277)14.28 
PSUs granted
270,405 18.99 
PSUs vested
(250,863)15.14 
PSUs forfeited
(56,167)25.41 
RSUs and PSUs outstanding at September 30, 2025
3,999,915 $15.54 
Summary of Share-Based Payment Arrangement, Performance Shares, Activity
The following table summarizes RSUs and PSUs activity during the nine months ended September 30, 2025:
Number of Shares
Weighted-
Average
Grant Date
Fair Value
RSUs and PSUs outstanding at December 31, 2024
4,842,670 $15.38 
RSUs granted
1,542,206 18.90 
RSUs vested
(1,520,059)15.92 
RSUs forfeited
(828,277)14.28 
PSUs granted
270,405 18.99 
PSUs vested
(250,863)15.14 
PSUs forfeited
(56,167)25.41 
RSUs and PSUs outstanding at September 30, 2025
3,999,915 $15.54 
Summary of Expense Relating to Employee and Nonemployee Stock-Based Payment Awards from Stock Options and RSUs
The following table summarizes stock-based compensation expense relating to employee and non-employee stock-based awards for the three and nine months ended September 30, 2025 and 2024, included in the condensed consolidated statements of operations as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of testing services$299 $418 $991 $1,232 
Cost of product51 234 390 776 
Cost of patient and digital solutions118 326 527 1,048 
Research and development1,146 1,775 3,912 5,163 
Sales and marketing1,782 2,786 6,512 8,757 
General and administrative5,022 11,384 14,441 32,919 
Total$8,418 $16,923 $26,773 $49,895